DNYANESHWAR SANAP, EU/UK QPPV, Head Regional Pharmacovigilance, Glenmark

•   Dnyaneshwar or Dnyan (better known as Dan in indistry circle) is a qualified physician of Indian origin, with total experience of more than 17 years.

•   Initiated career as a medical practitioner. After > 4 years of clinical practice experience and masters in pharmaceutical medicine (moreover upon developing interest into drug safety and clinical development field), joined pharma industry in 2009.

•   His first encounter with PhV occured during pursuing masters training at a WHO zonal center for Indian National Pharmacovigilance program (KEM hospital, Mumbai; 2007-08)

•   He has worked across PhV business models [academia (KEM Mumbai), vendor (TCS, Accenture), and sponsor-both developmental (AZ, UCB and BI) and post marketing (Sun /Taro and Glenmark)] since then.

•   During his previous association with Boehringer Ingelheim, he was responsible for safety survillence of one of it’s blockbuster medicinal product and was involved in measuring effectiveness of additional risk minimisation measure and development of AI based tool for assessment of safety data.

•   He is a qualified PV-QA auditor and a clinical trial medical monitor, has worked (as well as working) as EU-QPPV.